ACADIA Pharmaceuticals Inc. (ACAD) announced after the bell Wednesday that Uli Hacksell Ph.D., has retired as its Chief Executive Officer and as a member of the Board of Directors, effective today.
The company also announced that it has delayed its plans to submit its NUPLAZID NDA until the second half of 2015. The company had previously planned to submit the NDA in the first quarter of 2015.
ACADIA Pharmaceuticals gapped open sharply lower Thursday, but traded in a range for the majority of the session. Shares finished with a loss of 9.94 at $34.82 on the highest volume of the year. The stock sank to nearly a 1-month low.
For comments and feedback contact: editorial@rttnews.com
Business News